Cannabis Dosing in Family Medicine: Evidence-Based Guidance from Endocannabinoid System Research
This article reviews digital mental health interventions 2024 RCT findings focused on university students. The Minder mobile app trial showed modest improvements in anxiety and depression symptoms. These results highlight the potential of digital tools…
Cannabinoids in Mental Health Treatment: A Systematic Review and Meta-Analysis
Current evidence on cannabinoids for mental health and substance use disorders remains limited and inconclusive. This systematic review and meta-analysis highlights low-certainty data on efficacy and safety. Clinicians should interpret findings…
Cannabinoids in Mental Health Treatment: Efficacy and Safety Evidence
Clinical evidence for cannabinoids mental health treatment evidence remains limited and inconclusive. Current research does not establish clear efficacy or safety for mental disorders or substance use disorders. Patients and clinicians should approach…
Cannabinoid Clinical Trials: Mental Health Evidence
Clinical Takeaway Clinical Takeaway: Current randomized controlled trial evidence does not demonstrate established efficacy or safety of cannabinoids as primary treatment for mental disorders or substance use disorders. Existing research gaps mean…
Cannabinoid Clinical Trials: Mental Health Evidence Review
Clinical Takeaway Cannabinoid treatments show limited evidence of efficacy for mental health and substance use disorders in randomized controlled trials, with safety concerns requiring further investigation. Current clinical data does not support…
Endocannabinoid System Clinical Research Overview
This overview covers endocannabinoid system clinical trials focusing on mental health and substance use disorders. Current evidence shows limited support for cannabinoids as primary treatments. More rigorous trials are needed to clarify safety and…
Evaluating Safety in Cannabinoid Clinical Trials for Mental Health
Cannabinoid clinical trials mental health safety data reveal limited evidence supporting cannabinoids as primary treatments for mental disorders. Current trials show inconclusive efficacy and safety profiles. Patients should prioritize evidence-based…
Review of Cannabinoid Clinical Trials for Mental Disorders Safety
This cannabinoid clinical trials mental disorders safety review examines randomized controlled trials assessing efficacy and safety. Evidence remains limited and inconclusive for cannabinoids as treatments. Clinicians should interpret claims cautiously…
A recent study shows Marijuana is not effective for mental health disorders such as anxiety
Recent research on cannabis efficacy for mental health highlights mixed results, especially for anxiety disorders. This study shows marijuana is not effective for mental health conditions such as anxiety. Clinicians should carefully evaluate cannabis use…
Largest-ever Psychedelics Study Could Advance Use in Treating Mental Health Disorders
The largest psychedelic research mental health study marks a critical step toward evidence-based psychiatric care. This large-scale study aims to identify which patients benefit most from psychedelics. It could establish standardized protocols for…